CCIWA Call (888) 217-1376 24/7 confidential

Suboxone Treatment Providers in Washington, District of Columbia

83 clinicians with active NPPES enumerations in Washington list specialties that commonly prescribe buprenorphine for opioid use disorder. The Consolidated Appropriations Act of 2023 removed the X-waiver requirement. Any DEA Schedule II to V prescriber may now legally prescribe Suboxone, Subutex, Sublocade, or Zubsolv. Whether they actively take new MOUD patients is a separate question. You have to ask on the phone.

Washington, District of Columbia

83 providers in Washington

How to use this list. Call before showing up. Ask three things: do you accept new buprenorphine patients, do you take my insurance, and what is your earliest induction appointment. Most clinics that move fast can induct within a week. If a clinic delays past two weeks, keep calling other listings.

Washington at a glance

672,079
Residents
61.1 sq mi
Land area
34.9
Median age
$106,287
Median household income
3.4%
Uninsured (civilian)
10.7%
Families below poverty

Source: U.S. Census Bureau, ACS 5-year estimates (2023).

Overdose context for District of Columbia

District of Columbia reported a model-based drug poisoning death rate of 50.4 per 100,000 residents in 2021 (95% CI 48.6 to 52.3). That sits 77.2% above the national county mean of 28.5 per 100,000.

201933.7
202043.7
202150.4

Three-year change (33.7 to 50.4): +16.7 per 100,000.

County-level estimates are reported at the county level, not the city level. Source: NCHS Drug Poisoning Mortality by County (CDC dataset rpvx-m2md), 2019 to 2021 model-based estimates. NCHS urban/rural classification: Large Central Metro.

What this means for accessing buprenorphine here

District of Columbia ran a 2021 drug poisoning death rate of 50.4 per 100,000, well above the national county mean of 28.5. Quick access to office-based buprenorphine matters more here than in lower-rate counties. Uninsured rate is low here at 3.4%. Most prescribers bill commercial insurance directly. Sublocade injections, in particular, run several thousand dollars without coverage. Washington has roughly 672,079 residents. The provider list below maps to that population, not to the broader county.

Suboxone vs methadone for opioid use disorder

Suboxone is buprenorphine plus naloxone. It binds tightly to opioid receptors but only partially activates them. That partial-agonist behavior is why it has a ceiling on respiratory depression and a much lower overdose risk than methadone. It is also why it is delivered through office visits and prescriptions instead of daily clinic dosing.

Methadone is a full agonist. It is more powerful for severe long-term opioid use disorder, especially fentanyl-driven cases. The trade-off is that methadone is only legally dispensed through SAMHSA-certified opioid treatment programs, which means daily dosing visits, at least at the start.

If you are in Washington weighing the two, the decision usually comes down to severity, history of treatment, and your daily logistics. Buprenorphine is easier to access. Methadone is sometimes the better clinical fit.

Need daily-dose methadone instead? See methadone clinics in Washington.

Want a non-opioid alternative? See District of Columbia Vivitrol providers for monthly extended-release naltrexone.

State-level scoring, regulatory context, and full provider directory live on the District of Columbia Suboxone hub.